Abstract
Larynx is anatomically divided into three subsites: supraglottis, glottis, and subglottis. Glottic carcinoma is most common followed by supraglottic. Subglottis carcinoma is rare. Management of laryngeal cancer also involves organ-function preserving using multi-disciplinary management. Principle of management is to use single modality in early stage. Multimodality approach is used in advanced stage disease with combination of radiotherapy, chemotherapy, and surgery in different sequence to achieve tumor control as well as a good functional outcome. This chapter describes the workup treatment and radiation planning in a patient with laryngeal cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bertino G, Cacciola S, Fernandes WB Jr, Fernandes CM, Occhini A, Tinelli C, et al. Effectiveness of narrow band imaging in the detection of premalignant and malignant lesions of the larynx: validation of a new endoscopic clinical classification. Head Neck. 2015;37:215–22.
Elicin O, et al. Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: rationale, complications, toxicity rates, and oncological outcomes – a systematic review. Radiother Oncol. 2016;119(2):185–93.
Grégoire V, Evans M, Le Q-T, Bourhis J, Budach V, Chen A, et al. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018;126(1):3–24. https://doi.org/10.1016/j.radonc.2017.10.016.
Biau J, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019;134:1–9.
Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64:77–8.
Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2012;31(7):845–52.
Wolf GT, Fisher SG, The Department of Veterans Affairs Laryngeal Cancer Study Group, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12(2):153–9.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer, 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2009;6(11):21–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Pandit, S., Sapkota, S. (2020). Laryngeal Cancer. In: Mallick, S., Rath, G., Benson, R. (eds) Practical Radiation Oncology. Springer, Singapore. https://doi.org/10.1007/978-981-15-0073-2_36
Download citation
DOI: https://doi.org/10.1007/978-981-15-0073-2_36
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0072-5
Online ISBN: 978-981-15-0073-2
eBook Packages: MedicineMedicine (R0)